Quick Takeaways
- Column Group IV GP, LP filed SCHEDULE 13D for Eikon Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRZN).
- Disclosed ownership: 12%.
- Date of event: 06 Feb 2026.
Quoteable Key Fact
"Column Group IV GP, LP disclosed 12% ownership in Eikon Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRZN) on 06 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Column Group IV GP, LP | 8.3% | 4,460,979 | 0 | 4,460,979 | /s/ James Evangelista | James Evangelista, Attorney-in-Fact | 0001796356 |
| The Column Group IV, LP | 8% | 4,312,139 | 0 | 4,312,139 | /s/ James Evangelista | James Evangelista, Attorney-in-Fact | 0001796354 |
| The Column Group IV-A, LP | 0.3% | 148,840 | 0 | 148,840 | /s/ James Evangelista | James Evangelista, Attorney-in-Fact | 0001796353 |
| The Column Group Opportunity III, LP | 3.5% | 1,892,733 | 0 | 1,892,733 | /s/ James Evangelista | James Evangelista, Attorney-in-Fact | 0001931825 |
| The Column Group Opportunity III GP, LP | 3.5% | 1,892,733 | 0 | 1,892,733 | /s/ James Evangelista | James Evangelista, Attorney-in-Fact | 0001932874 |
| TCG Opportunity III GP, LLC | 3.5% | 1,892,733 | 0 | 1,892,733 | /s/ James Evangelista | James Evangelista, Attorney-in-Fact | 0001932445 |
| Tim Kutzkey | 12% | 6,353,712 | 0 | 6,353,712 | /s/ James Evangelista | James Evangelista, as Attorney-in-Fact for Tim Kutzkey | 0001614186 |
| Peter Svennilson | 12% | 6,353,712 | 0 | 6,353,712 | /s/ James Evangelista | James Evangelista, as Attorney-in-Fact for Peter Svennilson | 0001606074 |